Search

Your search keyword '"Porter, Rebecca"' showing total 610 results

Search Constraints

Start Over You searched for: Author "Porter, Rebecca" Remove constraint Author: "Porter, Rebecca"
610 results on '"Porter, Rebecca"'

Search Results

3. Preliminary Psychometric Analysis of a Neurobehavioural Screening Tool for Foetal Alcohol Spectrum Disorder

4. Abstract A061: Detection and dynamic monitoring of clonal hematopoiesis mutations in women receiving systemic therapies for high grade serous ovarian carcinoma

5. Abstract A083: Personalized targeted circulating tumor DNA (ctDNA) and T-cell responses after combined neoantigen vaccine and immune checkpoint blockade in ovarian cancer

6. Abstract B013: Folate receptor alpha (FRa) expression and correlation with other molecular alterations in high grade serous endometrial cancer (EC)

7. Epithelial to mesenchymal plasticity and differential response to therapies in pancreatic ductal adenocarcinoma

8. Building Communities of Care for Military Children and Families

10. A Correlational Study on Critical Thinking in Nursing as an Outcome Variable for Success

11. Satellite repeat RNA expression in epithelial ovarian cancer associates with a tumor-immunosuppressive phenotype

14. Tmem79/Matt is the matted mouse gene and is a predisposing gene for atopic dermatitis in human subjects

20. TP015/#1566 A phase 2, two-stage, study of mirvetuximab soravtansine (IMGN853) in combination with pembrolizumab in patients with microsatellite stable (MSS) recurrent or persistent endometrial cancer (EC)

22. Implementing Student Information Systems

23. Social equity in the data era: A systematic literature review of data‐driven public service research.

35. A phase 2, two-stage study of avelumab and axitinib in patients with mismatch repair proficient (MMR-P) recurrent or persistent endometrial cancer (EC).

36. A phase 2, two-stage study of mirvetuximab soravtansine (IMGN853) in combination with pembrolizumab in patients with microsatellite stable (MSS) endometrial cancer (EC).

42. Clinical Pan-Cancer Assessment of Mismatch Repair Deficiency Using Tumor-Only, Targeted Next-Generation Sequencing

46. The 21st-century paralegal: from interviewing prospective clients to managing documents at trial, today's paralegal participates in every aspect of an attorney's practice, bringing organization and perspective to complex legal tasks.

47. Privacy advocates tune in to concerns about ID technology.

48. Expanding the scope of clinical practice: the physical examination

Catalog

Books, media, physical & digital resources